ArticleCancer discovery2023

Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer.

Clare M Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.